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INTRODUCTION 
 
  
The yellow oleander (Thevetia peruviana) is an ornamental tree of the 
Apocyanaceae family that is widely distributed throughout the tropical to the 
subtemperate zones of the world. Their beautiful yellow flowers and prolific 
growth makes them popular shrubs for landscaping. These plants also may be 
found growing wild1.  
  
All parts of the plant contain cardiac glycosides. The major toxic 
effects are similar to that of digoxin overdose. The pathophysiology includes 
direct glycoside inhibition of sodium-potassium pump of the heart and 
increased vagotonia. Symptoms include vomiting, diarrhea, dizziness, 
bradycardia, sinus and AV nodal block and other cardiac dysrhythmias2,3. 
Fatal, DC shock resistant ventricular fibrillation or refractory cardiogenic 
shock may occur in severely poisoned patients4 .    
 
 Accidental ingestion occurs in children due to beautiful yellow flowers 
and the conspicuous green fruit5. Accidental poisonings have been reported 
form across the world, for example the Solomon Islands, Brazil and Australia. 
However, intentional poisoning in these regions is very uncommon6. But the 
use of seeds / fruits of yellow oleander as a method of suicide is common only 
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in Srilanka and South India. Following the death of two girls in 1980 which 
was widely reported in newspapers there has been a sudden increase in the 
number of cases of suicidal yellow oleander poisoning in Srilanka with 
thousands of cases occurring each year now with a case fatality rate of at least 
10%4. 
 
 Though the poisoning is a common method of suicide in South India 
there has been no published reports regarding this poisoning from South India. 
Data regarding incidence and case fatality rate of this poisoning in South 
Indian population is not available. The only Indian study involving large 
number of patients is from Eastern India. (300 cases, Bose TK et al, 1999).7 
Although clinical, biochemical and electrocardiographic characteristics of 
yellow oleander poisoning have been previously reported, social profile of 
patients has not been well studied. Hyperkalemia which has been noted in 
about 30% of the cases of yellow oleander poisoning in a Srilankan study has 
not been described in Indian studies involving 300 patients and 32 patients 
respectively.7,8 The risk factors for cardiotoxicity and outcome have also not 
been studied in detail in previous studies. Moreover further studies are 
required to support the use of multiple doses of activated charcoal and anti-
digoxin Fab fragments in yellow oleander poisoning. There has been only one 
clinical trial each to support their use in yellow oleander poisoning.9,10  
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 So this study was undertaken to find out the incidence of yellow 
oleander poisoning among admissions in general medicine wards of our 
hospital, to study the socio-clinical aspects, to find out correlation between 
clinical and biochemical parameters  with electrocardiographic changes and to 
assess possible risk factors for cardiotoxicity and outcome and to compare the 
results with previous published reports.                   
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REVIEW OF LITERATURE 
 
Yellow Oleander (Thevetia peruviana) - Plant description and 
distribution 
 It is a small ornamental tree belonging to family Apocynaceae which 
grows to about 10 to 15 feet high. The leaves are spirally arranged, linear, 
lanceolate and about 13 to 15cm in length. Flowers are bright yellow and 
funnel shaped with 5 petals spirally twisted. The fruits are somewhat globular, 
slightly fleshy and have a diameter of 4 to 5cm. The fruits which are green in 
colour, become black on ripening. Each fruit contains a single nut, light brown 
in colour and triangular in shape with two cells, each enclosing a pale yellow 
seed.5 
These plants are widely distributed throughout the tropical to the sub- 
temperate zones of the world. Their beautiful yellow flowers and prolific 
growth makes them popular shrubs for landscaping. These plants also may be 
found growing wild1. It is often planted in numbers as a hedge11.  
 
Historical and Medicolegal aspects 
Many myths are associated with this plant. In the West Indies, the nut is 
carried in the pocket in the belief that it will ward off hemorrhoids. In   East 
Africa, it is put in the hand of an infant at birth as a good luck token. In 
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Africa, the seed kernels are occasionally chewed to cause purging. In the 
Philippines, half of one leaf in given as emetic and purgative. The sap and 
bark have been utilized in small amounts to treat malarial fever as well as to 
induce vomiting and purging. The sap also has been applied to sores and 
ulcers, also to tooth cavities and decayed teeth to relieve toothache11. 
 The toxicity of the plant has been generally known since the sixteenth 
century. It’s Sankrit name “Ashwamarak” is translated as horse killer11. 
Accidental poisoning occurs in children as they may play with and taste the 
bright yellow flowers and conspicuous green fruit. The seeds are used for 
suicide attempts particularly by young people especially in northern parts of 
Srilanka and South India. Other medicolegal aspects include use of roots and 
seeds with water or oil for procuring criminal abortion and seeds for poisoning 
cattle.5 Yellow oleander glycosides proved effective in patients with heart 
failure and atrial fibrillation in studies carried out in 1930s, however digoxin 
has been preferred because of less frequent gastrointestinal side effects.12 
Epidemiology of yellow oleander poisoning  
Ingestion of oleander seeds or leaves is a cause of accidental poisoning 
worldwide, particularly among children.6,13 Cases have been reported from 
places as diverse as Hawaii, the Solomon Islands, Southern Africa, Australia, 
Europe, the Far East and the United States.14,15 However the use of seeds / 
fruits of yellow oleander as a method of suicide is common only in Srilanka 
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and South India. This method of suicide is common among adolescents and 
young adults with a female preponderance4,7. Currently, thousands of cases of 
yellow oleander poisoning occur in Srilanka every year with a case fatality 
rate of atleast 10%.4 The exact incidence of the disease in Indian population is 
not known. Bose TK et al (1999) noted a case fatality rate of 4.6% among 300 
cases in Eastern India.7 
 
Poisonous parts  
 All parts of the plant are poisonous especially the seeds / kernels of 
fruit.16 
 
Poisonous agents  
 Thevetin A & B, Thevetoxin, Peruvoside, Ruvoside and Neriforin 
which are cardiac glycosides are the poisonous agents found in this plant17.  
 
Pathophysiology of toxicity 
 The poisonous agents found in yellow oleander plant are cardiac 
glycosides. These bind to a site on the cell membrane, producing reversible 
inhibition of sodium (Na+) – potassium (K+) – adenosinetriphosphatase                 
(ATPase) pump, which causes increased intracellular sodium and decreased 
intracellular potassium. In myocytes, elevated intracellular sodium 
concentrations produce increased intracellular calcium concentrations via a 
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sodium (Na+)- calcium (Ca2+) exchanger. Excessive intracellular calcium is 
concentrated in the sarcoplasmic reticulum and released in excess, with 
depolarization.18  
 Release of excessive calcium results in enhanced cardiac contractions 
which are delayed after depolarizations and manifest clinically as after 
contractions, such as premature ventricular contractions. Cardiac glycosides 
also have vagotonic effects, resulting in bradycardia and heart blocks. 
Inhibition of Na+-K+-ATPase in skeletal muscle results in increased 
extracellular potassium and contributes to hyperkalaemia18. Severe 
hyperkalemia can contribute to atrioventricular (AV) block and depressed 
myocardial excitability.19  
 Cardiac glycosides primarily affect cardiovascular and gastrointestinal 
systems of which effects on the cardiac system are most significant. The 
pathophysiology that produces cardiotoxicity involves prolonging refractory 
period in the atrioventricular (AV) node, shortening refractory periods in the 
atria and ventricles, and decreasing resting membrane potential (increased 
excitability). Any dysrhythmia characterized by both increased automaticity 
and depressed conduction is suggestive of cardiac glycoside toxicity.18  
 Dysrhythmias often associated with cardiac glycoside toxicity include 
bradydysrhythmias, sinus bradycardia with all types of atrioventricular (AV) 
nodal block, junctional rhythms and sinus arrest. Dysrhythmias characterized 
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by increased automaticity and conduction blockade, are highly suggestive of 
cardiac glycoside toxicity. These include tachydysrhythmias such as atrial 
tachycardia with block, paroxysmal atrialtachycardia with block, bidirectional 
ventricular tachycardia and ventricular fibrillation18.  
Pharmacokinetics 
 Thevetin is easily absorbed from the gastrointestinal tract. Thevetin 
glycosides occur in higher concentrations in heart muscle than in blood.20  
Thevetin probably has a shorter half-life than digoxin and a lower risk of 
accumulation in the body17.  
Fatal dose  
 Although previous authors have suggested that between four and seven 
seeds was the lethal dose2,3, recent studies in Srilanka involving larger number 
of patients found that there was no exact relationship between number of seeds 
ingested and outcome.4    
 
Clinical features of yellow oleander poisoning  
Symptoms  
 Closely resembles digitalis poisoning with gastrointestinal and cardiac 
symptoms.  
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Gastrointestinal symptoms  
  Symptoms are nonspecific and include nausea, vomiting, diarrhea and 
abdominal pain.2,3  
Cardiac symptoms  
Include palpitations, shortness of breath, giddiness etc.18  
Neurological symptoms  
 Pupils may be dilated.21   and excessive salivation has been reported.20 
Paraesthesias and weakness have also been reported.20 Symptoms are often 
nonspecific and include giddiness, numbness (especially of tongue and oral 
mucous membranes), altered mental status (eg. Disorientation, confusion, 
drowsiness, lethargy etc.) and occasionally seizures. 18 
 
Complications  
1. Cardiogenic shock can develop secondary due to arrhythmias. The 
various arrhythmias that are noted in yellow oleander poisoning are 
sinus bradycardia, sino-atrial block, all types of atrioventricular (AV) 
block including Mobitz type II second degree AV block, junctional 
rhythm, supraventricular tachycardia, atrial fibrillation, artrial flutter, 
bundle branch block, ventricular ectopics, ventricular tachycardia and 
ventricular fibrillation.8  
2. Hyperkalemia is seen in severe cases of yellow oleander poisoning8.   
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3. Acute renal failure can develop secondary to cardiogenic shock.  
4. Acid base disturbance-circulatory collapse can cause metabolic 
acidosis.  
Postmortem appearance 
 Subendocardial and perivascular hemorrhage with focal myocardial 
edema has been noted.7 Generalised hemorrhages and signs of gastrointestinal 
irritation have also been found.5  
 
Course and prognosis  
 In severe poisoning diarrhea, vomiting, abdominal pain and sinus 
bradycardia are early features. Hyperkalemia, conduction block and 
ventricular ectopics indicate serious toxicity .20 Indicators of a poor prognosis 
include multiple and varying cardiac rhythms, with sino-atrial and atrio-
ventricular blocks in combination with ventricular excitability, ST depression 
over 2.5mm and unresponsiveness to atropine.2 Conduction block and sinus 
bradycardia may persist for 5 days after ingestion. Patients usually recover 
from these if no underlying cardiovascular pathology exist 20.  
Management  
Investigations  
 Blood glucose estimation: assess for hypoglycemia as a possible cause 
of altered mental status.  
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Electrolytes  
 Hyperkalemia occurs in severe yellow oleander poisoning. The degree 
of hyperkalemia correlated with the serum digoxin cross reactive cardiac 
glycoside concentration8. Severe hyperkalemia can contribute to atrio- 
ventricular (AV) block and depressed myocardial excitability19. Hypokalemia 
can also exacerbate cardiac glycoside toxicity due to enhanced binding of 
cardiac glycoside to Na+-K+ ATPase pump22. Electrolytes has to be checked 
repeatedly, particularly serum potassium levels. Hypercalcemia and 
hypomagnesmia also can exacerbate cardiac glycoside toxicity.  
Blood urea and creatinine  
    Acute renal failure can develop secondary to cardiogenic shock. Renal 
insufficiency is associated with elevated endogenous digoxin like 
immunoreactive factors that can give false – positive digoxin assay results18. 
Renal function has to be closely monitored.  
Cardiac glycoside level  
 Some plant glycosides cross react with commonly used digoxin 
radioimmunoassay and digoxin fluorescence polarization immunoassays23. 
Detectable levels of cardiac glycosides have been associated with ingestion of 
foxglove and oleander however levels do not correlate with severity of illness. 
Beyond its qualitative usefulness in oleander toxicity, however the digoxin 
serum levels clinical significance is unknown. Negative digoxin 
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radioimmunoassay does not rule out a plant glycoside exposure18. In one of 
the Srilankan studies there was a correlation between degree of hyperkalemia 
and the serum digoxin cross reactive cardiac glycoside concentration. But they 
could not identify cardiac glycoside levels or hyperkalemia at presentation as 
determinants of mortality8.  
 
Electrocardiogram (ECG) and continuous cardiac monitoring  
 To find out the cardiac rhythm, identify life threatening arrhythmias 
and for treatment. 
Hemoglobin level - To determine if anemia is a cause or potential 
complicating factor for dysrhythmia or hypotension.  
Arterial blood gas analysis – To identify metabolic acidosis which may 
develop secondary to circulatory collapse. 
Sample collection – Remaining parts of the ingested plant and gastric 
contents are useful for botanical identification. Plant portions found in 
vomitus should be stored in a plastic bag for forensic examination.  
Treatment  
 General principles include providing general supportive care, 
immediate gastric decontamination, preventing further exposure and 
absorption, administering antidote and correction of arrhythmias and 
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electrolyte disturbance. Management is very similar to that of digoxin 
poisoning.  
Decontamination  
If consciousness is not impaired, emesis can be induced or gastric 
lavage can be performed. Gastric lavage is most useful when started within 
sixty minutes after ingestion24.  
 
Activated charcoal  
 Activated charcoal can be given 60-100g orally or via gastric tube, 
mixed in aqueous slurry24. Multiple doses of activated charcoal (50 g of 
activated charcoal every 6 hrs for 3 days) has been found to be more effective 
in reducing deaths and life-threatening cardiac arrhythmias after yellow 
oleander poisoning than single dose. After absorption into the systemic 
circulation cardiac glycosides are secreted into the gut lumen by the action of 
p-glycoprotein (enterohepatic circulation). In gut, activated charcoal binds the 
secreted glycoside and encourages further secretion, thereby causing a rise in 
glycoside excretion. Through the interruption of the enterohepatic circulation 
of the cardiac glycosides in yellow oleander, multiple doses of activated 
charcoal improves outcome in yellow oleander poisoning 9.  
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Antidote  
 Anti-digoxin Fab fragments are a safe and effective treatment for 
serious cardiac arrhythmias induced by yellow oleander.10 The investigators 
used 1200mg of antidigoxin Fab fragment in a randomized controlled trial 
involving 66 patients. Flanagan RJ and Jones AL recommends that the 
approximate dose of Fab fragments (mg) is 80 times the digoxin body burden 
(mg). They recommend a dose of 380mg of anti-digoxin Fab fragment in an 
adult if neither the dose ingested nor the plasma digoxin / digitoxin 
concentration is known. The dose for elderly patients or those with renal 
impairment should be similar to that for those with normal renal function.  The 
antibody fragments are given intravenously over 15-30 minutes after dilution 
to at least 250ml with 0.9% (w/v) sodium chloride. Fab fragments are 
generally well tolerated. Adverse effects include hypokalemia and 
exacerbation of congestive cardiac failure; renal function could be impaired in 
some patients.25 Indications of use include hyperkalemia (>5.0meq/l), life-
threatening supraventricular and ventricular dysrhythmias and 
hemodynamically significant bradycardia unresponsive to atropine.18  
Treatment of arrhythmias  
    Since onset of action of Fab fragments may take 30-60min, intervening 
treatment of significant complications should be done.  
 
 15
Bradydysrhythmias  
 Atropine and cardiac pacing can be tried. Patients requiring 
transcutaneous cardiac pacing should receive Fab fragments prior to it. 
Transvenous pacing and use of isoproterenol can result in degeneration of 
cardiac rhythm and should be avoided. Overdrive pacing should not be used 
for the control of ventricular dysrhythmias.18  
Tachydysrhythmias  
 Phenytoin and lidocaine are agents of choice. Magnesium has been 
reported to reverse digoxin induced dysrhythmias and may be useful as long 
as anuric renal failure is not present. Quinidine and procainamide may 
enhance cardiac glycoside toxicity by slowing conduction across AV node; 
both should be avoided.18  
 Cardioversion is used as a last resort, as it may induce intractable 
ventricular fibrillation. Fab fragments should be given with cardioversion.  If 
time permits, cardioversion should be attempted after a loading dose of 
phenytoin and at a significantly reduced initial power setting of 5-10J.18    
Hyperkalemia  
Glucose, insulin, sodium bicarbonate and salbutamol may be used to 
facilitate redistribution of potassium intracellularly. However, salbutamol may 
precipitate cardiac dysrhythmias. Life-threatening hyperkalemia should be 
treated with Fab fragments. Calcium should be avoided in hyperkalemia due 
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to cardiac glycoside toxicity as already there is excess of calcium 
intracellularly and results in overloading of myocytes with calcium, increased 
dysrhythmias, and a higher rate of death.18  
 
Cardiac arrest 
 Give 10-20 vials of Fab and treat with standard advanced cardiac life 
support (ACLS) principles. Prolonged efforts at resuscitation may be 
warranted until Fab fragments begin to work.18  
Elimination  
  Forced diuresis, hemoperfusion and hemodialysis are ineffective in 
enhancing the elimination of cardiac glycosides due to their large volume of 
distribution. Hemodialysis will efficiently remove potassium from 
extracellular fluid.18 
Analysis of published Indian reports  
 Analysis of 300 patients of yellow oleander poisoning studied in BS 
Medical College, Bankura from 1986 to 1990 showed the following.  
- Majority i.e., 246 (82%) were females. 226 (75.33%) young in the age 
group (11-20 years). Delay in taking treatment was between 6 to 8 hrs. 
Number of seeds ingested varied from ½ to fifteen. 97.33% ingested 
seeds in the crushed form. 52% were asymptomatic, 30.66% had 
vomiting and 12% had palpitation. 138 (46%) revealed various 
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arrhythmias. Sinus bradycardia in 68 cases and ST-T changes present in 
39.33%. Number of seeds ingested did not bear any relationship with 
ECG changes.  
- Analysis of clinical profile of 32 cases of yellow oleander poisoning at 
VSS Medical College, Burla. Majority were females in the age group 
16-20 yrs. Symptoms were vomiting in 46.9% of cases, numbness 
sensation in 43.8%, dryness of mouth in 25%, diarrhea in 18.8% of 
cases. Routine blood and urine examination were within normal limits. 
There was no biochemical abnormalities detected. The ECG change 
noted were sinus bradycardia in 17 (53%), 1° AV block in 5 (15.6%), 
III° AV block in 1 (3.1%), ST elevation in 2 (6.2%), ST depression in 4 
(12.5%) and T wave changes in 6 (18.8% of cases).  
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AIMS AND OBJECTIVES 
 
1. To find out the incidence of yellow oleander poisoning.  
2. To analyse the socio-clinical aspects.  
3. To correlate clinical and biochemical data with electrocardiographic 
changes.  
4. To identify the possible risk factors for cardiotoxicity and outcome.  
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MATERIALS AND METHODS 
 
Setting  
 Department of Medicine, Government Rajaji Hospital and Madurai 
Medical College, Madurai. There was no other collaborating department.  
Design of study  
 Prospective study  
Period of study  
 August 2005 to January 2006.  
Sample size  
 Hundred and eleven cases of yellow oleander poisoning that satisfied 
the inclusion and exclusion criteria.  
Selection of study subjects  
 Yellow oleander poisoning cases who fulfilled the inclusion and 
exclusion criteria. 
Inclusion criteria  
1. Those admitted in general medicine wards with history of yellow 
oleander ingestion during the period of August 2005 to January 2006.  
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Exclusion criteria  
1. Pediatric cases were excluded (<13 yrs of age). 
2. Those with underlying severe cardiac, renal or hepatic disease were 
excluded.   
3. Patients who were taking the following drugs –digoxin, diuretics, 
verapamil, diltiazem, β blockers, ACE inhibitors, amiodarone, calcium 
and potassium supplements were excluded.  
Definitions  
 The definitions adopted during the study period with reference to 
selected entities are furnished below.  
1. Cardiotoxicity  
 Yellow oleander poisoning cases were divided into no carditoxicity, 
 some carditoxicity and severe cardiotoxicity groups based on 
 electrocardiographic changes.   
a. No cardiotoxicity  
  This group included patients whose electrocardiogram showed 
  sinus  rhythm or sinus tachycardia only.  
b. Some cardiotoxicity  
  This group included patients whose electrocardiogram showed 
  any one of the following changes. 
1. Sinus bradycardia.  
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2. First-degree atrioventricular (AV) block.  
3. Mobitz Type–I second-degree atrioventricular (AV) 
block. 
4. Atrial ectopics. 
5. ST segment and T wave changes that are characteristic 
of digitalis effect / toxicity.   
c. Severe cardiotoxicity  
 This group included patients whose electrocardiogram showed 
 any one of the following changes:  
1. Sino-atrial (SA) block.  
2. Junctional rhythm.  
3. Mobitz Type–II second-degree atrioventricular (AV) 
block.  
4. Third-degree atrioventricular (AV) block.  
5. Atrioventricular (AV) dissociation.  
2. Consumption in empty stomach  
 This included patients who had not consumed anything for at least 8 hrs 
 before consuming the poison. 
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3. First aid at home  
 This refers to method adopted by local people to bring out the poison. 
 The method mostly used was to induce vomiting using salt water, 
 tamarind water, soap water etc.  
4. Serum potassium level  
 Hypokalemia - Defined as serum K+ less than 3.5meq/l.  
 Hyperkalemia - Defined as serum K+ greater than 5.0meq/l. 
 
Methods  
 Selected sociodemographic, clinical, biochemical, electrocardiographic 
and treatment details were collected from the patients and recorded in a 
proforma.  
Sociodemographic data consisted of  
- Age  
- Sex  
- Locality  
- Occupation  
- Income  
Data regarding poisoning comprised of part ingested, quantity of poison, 
method of ingestion, whether consumption in empty stomach or after food, the 
intention behind poisoning, time of ingestion, first aid at home, consumption 
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to admission interval, treatment given, duration of hospital stay and the type of 
outcome. 
Clinical date comprised of  
  Symptom analysis, pulse rate, rhythm, blood pressure and systemic 
examination.  
Laboratory data included  
- Blood sugar  
- Blood Urea  
- Serum Creatinine  
- Serum Na+, K+, Cl-, HCO-3 values  
- Electrocardiogram (ECG) 
  
 Blood urea, sugar, serum creatinine and serum Na+, K+, Cl- and HCO-3 
values were estimated using ERBA XL300 automated analyzer. The blood 
urea, sugar, creatinine and serum Na+, K+, Cl-, HCO-3 were measured at the 
time of admission before instituting treatment. 12 lead ECG, including rhythm 
strip in leads II and V1 was taken in all patients. 12 lead ECG including 
rhythm strip was taken at admission before instituting treatment and repeated 
depending on the clinical status.  
Ethical committee approval 
  The present project was approved by the ethical committee.  
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Consent  
 An informed consent was obtained from all patients who were included 
in the study.  
Limitations  
1. Continuous ECG monitoring and serial levels of electrolytes especially 
serum potassium could not be done due to technical constraints.  
2. Estimation of cardiac glycoside level was not done due to 
nonavailability and financial constraints.  
3. Activated charcoal, anti-digoxin Fab fragments were not administered 
and temporary pacemaker not used due to financial and technical 
constraints.  
4. Arterial blood gas analysis was not done due to nonavailability at the 
time of the study.  
Conflicts of interest  
 There was no conflict of interest.  
Financial support  
 Nil  
Statistical analysis  
 Data were entered in Microsoft Excel spreadsheet and analysed 
utilizing the software-Epidemiological Information Package 2002 (Epi Info 
2002) – developed by the Centre for Disease Control and Prevention, Atlanta 
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for World Health Organisation. Frequencies, percentages, range, mean, 
standard deviation and ‘p’ values were calculated using this package.  
 Chi Square test was done to find out the significance of relationship 
between the groups. Since the variances were not homogenous, 
KRUSKULWALLY (X2 test) was used to find out the significance of 
difference. The difference was considered to be significant if the ‘p’ value was 
less than 0.05.  
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RESULTS 
 
Incidence of Yellow Oleander Poisoning 
The incidence of yellow oleander poisoning among total number of 
admissions in general medicine wards of Government Rajaji Hospital, 
Madurai during the study period was 13.2 per 1000 admissions. It accounted 
for 91.7% of the cases of plant poisoning. In general, 10% of the cases among 
the total number of admission in general medicine wards were poisoning 
cases. Among the poisoning cases, 85.7% were chemical poisoning and 14.3% 
plant poisoning. Among the total number of poisoning cases, yellow oleander 
accounted for 13.1% of the cases. This is explained using a flow chart.  
 
 
 
 
 
 
 
 
Poisoning Cases – 845 (10%) 
Chemical – 724 (85.7%) Plant – 121 (14.3%) 
Yellow Oleander -111 (91.3%) Others – 10 (8.7%) 
Total No of Admissions - 8432 
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Distribution of cases in relation to age  
 The maximum number of cases occurred in the age group 20-29 
(50.5%) followed by age group 13-19 (21.6%) and 30-39 (16.2%) 
respectively. The age of the patients ranged from 13-62 years. The mean age 
and standard deviation was 27.05±9.76. The mean age of poisoning among 
males was 27.96±9.6 and that of females 26.31±9.91. The difference in the 
mean age of males and females was not statistically significant (p=0.2458). 
The graph gives the distribution of cases according to age group.  
 
Distribution of cases in relation to gender  
 Among the total of 111 cases, 50 (45.05%) were males and 61 
(54.95%) were females. The ratio of females : males was 1.22:1, but the 
difference was not statistically significant (p=0.56).  
 
Distribution of cases in relation to income 
 72.5% of the patients who were earning had income below Rupees two 
thousand per month. The mean income was Rupees 2105.31±3623.13, range 
being Rs. 200 – 30,000. The details are given in the table below.  
 
 
 
 28
Table No. 1 Distribution of cases in relation to income 
Monthly Income In Rs. No % 
<1000 28 25.2 
1000 – 1999 30 27 
2000-2999 11 9.9 
3000-3999 4 3.6 
4000 and above 7 6.3 
Not earning 31 27.9 
 
Intention behind poisoning 
 The intention behind poisoning was suicidal in majority of cases 
(82.9%) and accidental in 1.8%. In 15.3% of cases, the poisoning attempt was 
done just to frighten others for some personal gain or to resolve conflict. There 
were no cases of homicidal poisoning.  
 
Table No.  2 Intention behind poisoning  
Intention behind poisoning  No. of cases (%) 
Suicidal  90 (82.9%) 
Accidental  2 (1.8%) 
Homicidal  - 
Others  19 (15.3%) 
Total  111 (100%) 
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Time of ingestion  
 As you can see in the graph, in majority of cases (85.5%) the poisoning 
between 6am – 6pm.  
TIME OF INGESTION
0
5
10
15
20
25
30
00.00 -
03.00
03.01  -
06.00
06.01 –
09.00
09.01 –
12.00
12.01 –
15.00
15.01 –
18.00
18.01 –
21.00
21.01 –
24.00
TIME
N
O
. O
F 
C
A
SE
S
 
 
Electrocardiographic manifestations of yellow oleander poisoning  
The most common abnormal findings were sinus bradycardia (33.6%) 
and ST-T changes (41.8%) (which were similar to that described for digoxin 
effect / toxicity). Sino-atrial block, third-degree AV block and first-degree AV 
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block were noted in 7 cases each. Mobitz type –II second-degree AV block 
which is not described in digitalis toxicity occurred in two cases. Depending 
on the ECG changes all cases of yellow oleander poisoning were divided into 
no, some and severe cardiotoxicity groups (Refer definitions in materials and 
methods). In majority of the cases (61.8%) some form of cardiotoxicity was 
present. Severe cardiotoxicity was present in about 1/5th of the cases. The 
details are depicted below in the table and the pie diagram. 
Table No. 3 ECG changes in yellow oleander poisoning 
Cases 
Cardiotoxicity ECG changes 
No. % 
Sinus rhythm  36 32.7 No 
Sinus tachycardia  6 5.5 
Sinus bradycardia  37 33.6 
Atrial ectopics  1 0.9 
ST-T changes (digoxin 
effect/toxicity ) 
46 41.8 
First-degree AV block  7 6.4 
Some 
Mobitz type I second-
degree AV block  
2 1.8 
Sino-atrial (SA) block  7 6.4 
Junctional rhythm  3 2.7 
Mobitz Type II second- 
degree AV block  
2 1.8 
Third-degree AV block  7 6.4 
Severe 
AV dissociation  2 1.8 
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Relationship between part ingested and cardiotoxicity  
 
 Majority of the patients had taken either the fruit or seed, 52.8% and 
44.6% respectively. 3 of the patients had taken the outer fleshy covering of the 
nut alone and these patients had no cardiotoxicity. There was no statistically 
significant difference in the cardiotoxicity caused by fruit and seed 
(p=0.9582). The details are given in the table given below.   
 
Table No. 4 Part ingested and Cardiotoxicity 
 
Cardiotoxicity  
No 
cardiotoxicity 
Some 
cardiotoxicity  
Severe 
cardiotoxicity  
Part ingested 
No.  % No.  % No.  % 
Fruit  20 48.8 27 57.4 10 50 
Seed  18 43.9 20 42.6 10 50 
Flower  - - - - - - 
Leaves  - - - - - - 
Root  - - - - - - 
Other parts  3 7.3 - - - - 
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Relationship between quantity of poison ingested and cardiotoxicity  
 
  The mean number of seeds / fruits ingested in no cardiotoxicity group 
was 2.33 and that in severe cardiotoxicity group was 3.85. The difference was 
statistically significant (p=0.0001). The range, mean and standard deviation of 
quantity of poison in each of the groups is depicted in the table and the graph.  
 
Table No. 5 Quantity of poison ingested and cardiotoxicity 
 
Cardiotoxicity  Range  Mean  Standard Deviation  
No cardiotoxicity  1-5 2.33 1.65 
Some cardiotoxicity 1-10 3.47 1.54 
Severe cardiotoxicity 1-18 3.85 1.93 
Total  1-18 3.26 2.27 
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Relationship between method of ingestion of poison and cardiotoxicity  
 
  The method of ingestion of poison was crushed in 50.5% of the cases, 
chewed in 40.5% and swallowed in 9%. 76.8% of those who had taken the 
poison in the crushed form had some form of cardiotoxicity compared to 50% 
in those who had taken the poison chewed. The difference between the groups 
was statistically significant (p=0.0001). The details are shown in the table 
below.  
 
Table No. 6 Method of ingestion and cardiotoxicity 
 
Cardiotoxicity 
No 
cardiotoxicity 
Some 
cardiotoxicity 
Severe 
cardiotoxicity 
Total 
Method of 
ingestion 
No % No % No % No % 
Crushed  13 23.2 32 57.1 11 19.7 56 100 
Chewed  22 50 14 31.8 8 18.2 44 100 
Swallowed  7 70 2 20 1 10 10 100 
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Relationship between manner of consumption and cardiotoxicity  
 
 60.4% of the patients had consumed the poison in empty stomach and 
the rest after food. 70.2% of the patients who had taken the poison in empty 
stomach had some form of cardiotoxicity compared to 48.8% in patients who 
took the poison after food. The difference between the groups was statistically 
significant (p=0.041). The details are shown in the graph and the table given 
below.  
 
Table No. 7 Manner of consumption and cardiotoxicity 
 
Cardiotoxicity 
No 
cardiotoxicity 
Some 
cardiotoxicity 
Severe 
cardiotoxicity 
Total 
Manner of 
consumption 
No % No % No % No % 
In empty 
stomach  
20 29.8 35 52.5 12 18.0 67 100 
After food  22 51.2 13 30.2 8 18.6 43 100 
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Relationship between first aid and cardiotoxicity  
 
 Majority were not given first aid (57.7% of cases).  59.6% of patients 
who were given first aid developed some form of cardiotoxicity compared to 
63.5% in patients who were not given first aid (Refer definitions in materials 
and methods). The difference between the groups was not statistically 
significant (p=0.8529). The details are given in the table below.  
 
Table No. 8 First aid and cardiotoxicity 
Cardiotoxicity 
No 
cardiotoxicity
Some 
cardiotoxicity
Severe 
cardiotoxicity 
Total First aid 
No % No % No % No % 
Given  19 40.4 20 42.5 8 17.1 47 100
Not given  23 36.5 28 44.4 12 19.1 63 100
 
 
 
 
 
 
 
 36
Relationship between time of first aid and cardiotoxicity  
 
 In patients who were given first aid 2 hrs after consumption of poison, 
all of them developed cardiotoxicity compared to 48.4% in patients who were 
given first aid within one hour. The mean time of first aid in no, some and 
severe cardiotoxicity groups were 34.4 min, 112.9 min and 132.5 min 
respectively. The difference between the groups was statistically significant 
(p=0.0038). The details are given in the table below and explained using a 
graph.   
 
Table No.9 Time of first aid and cardiotoxicity 
Cardiotoxicity 
No 
cardiotoxicity 
Some 
cardiotoxicity 
Severe 
cardiotoxicity 
Total 
Time of first 
aid 
No % No % No % No % 
1-60 minutes  16 51.6 11 35.5 4 12.9 31 100 
61-120 
minutes  
3 37.5 4 50.0 1 12.5 8 100 
>120 minutes  - - 5 62.5 3 37.5 8 100 
Range  10-120 
min. 
 5-390 min  
30-420 
min. 
   
Mean  34.4 min  112.9 min  132.5 min    
S.D 32.5  126.7  126.1    
 
 
 37
Relationship between consumption to admission interval and 
cardiotoxicity  
 
 The mean delay in getting admitted to Government Rajaji Hospital 
(GRH), Madurai after consumption of poison was 12.72±4.6 hrs, the range 
being 1-62 hrs. The mean delay in no, some and severe cardiotoxicity group 
was 13.32, 12.25, and 12.36 hrs respectively. The difference between the 
groups was not statistically significant (p=0.6012). The details are given in the 
table below.   
 
Table No. 10 Consumption to admission interval and cardiotoxicity 
Cardiotoxicity Time interval 
between 
consumption to 
admission (in hrs) 
No 
cardiotoxicity 
Some 
cardiotoxicity
Severe 
cardiotoxicity 
Total 
Range  1-62 1-61.5 1.25-20.25 1-62 
Mean  13.32 12.25 12.36 12.72 
S.D.  4.38 4.73 4.92  4.6 
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Relationship between symptoms and cardiotoxicity  
 
 The most common symptoms of yellow oleander poisoning were 
vomiting (73%), numbness of tongue and lips (57.7%), giddiness (56.8%) and 
diarrhea (27.9%). The relationship between three symptoms, i.e., vomiting, 
diarrhea, altered mental status with cardiotoxicity was analysed. In those 
patients who did not have any one of the above three symptoms, only 27.3% 
had features of cardiotoxicity. In those patients who had at least one of the 
three symptoms, 66.7% had features of cardiotoxicity. Approximately 75% of 
the patients who had at least two symptoms or all the three symptoms had 
features of cardiotoxicity. The difference between the groups was statistically 
significant (p=0.0005). The details are shown in the tables given below.  
Table No. 11 Symptoms of yellow oleander poisoning 
Symptoms  No  % 
Vomiting  81 73 
Abdominal pain  19 17.1 
Diarrhea  31 27.9 
Giddiness  63 56.8 
Numbness of tongue & lips  64 57.7 
Altered mental status  19 17.1 
Blurred vision  21 18.9 
Palpitation  23 20.7 
Shortness of sheath  8 7.2 
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Table No.12 Symptoms and cardiotoxicity 
 
Cardiotoxicity 
No 
cardiotoxicity
Some 
cardiotoxicity
Severe 
cardiotoxicity 
Total Presence of 
symptoms 
No % No % No % No % 
Vomiting (80) 24 30 39 48.75 17 21.25 80 100
Diarrhoea (31) 7 22.58 15 48.38 9 30.03 31 100
Altered (18) 
mental status  
5 27.78 9 50 4 22.22 18 100
None of the 
above three 
symptoms  
16 72.7 4 18.2 2 9.1 22 100
Atleast one  
symptom  
17 33.3 26 51.0 8 15.7 51 100
Atleast two  
symptoms  
8 24.25 17 51.5 8 24.25 33 100
All the three 
symptoms  
1 25 1 25 2 50 4 100
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Vital signs and biochemical parameters  
 
 The range, mean and standard deviation values of pulse rate, blood 
pressure and biochemical parameters are given in the table below. The mean 
values of all these parameters were within normal limits. Pulse rate was 
irregular at admission in 16.2% of the cases, in the rest the pulse rate was 
regular. Hypotension was present in two cases at admission. 
 
Table No.13 Vital signs and biochemical parameters  
 
Parameter  Range  Mean  S.D 
Pulse rate at admission  36-140 80.07 20.9 
Systolic blood pressure (mmHg) 70-150 111.8 18.63 
Diastolic blood pressure (mmHg) 40-100 73.75 10.57 
Blood urea (mg/dl) 15-72 27.19 10.33 
Blood sugar (mg/dl) 56-235 91.54 31.77 
Serum Creatinine (mg/dl) 0.6-1.8 0.9 0.32 
Na+ (meq/l) 122-160 138.44 5.23 
Cl– (meq/l) 90-106 97.69 2.83 
HCO3- (meq/l) 15-24 19.33 1.84 
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Relationship between serum potassium values and cardiotoxicity  
 
 Serum potassium levels was measured at time of admission in 97 out of 
111 cases. Out of these only two cases had hyperkalemia, 7 cases had 
hypokalemia and in the majority (90.7%) serum potassium values were within 
normal limits. The mean serum potassium value in no, some and severe 
cardiotoxicity groups were 3.85, 4.09 and 4.16 meq/l respectively. The 
difference between the groups was statistically significant (p=0.0201). The 
details are given in the two tables shown below and explained using a graph.  
 
Table No. 14 Serum potassium levels and cardiotoxicity 
 
Serum potassium values 
Cardiotoxicity Range  
(meq/l) 
Mean 
(meq/l) 
Standard 
Deviation 
(S.D.) 
No cardiotoxicity  3-4.6 3.85 0.38 
Some cardiotoxicity  3.4-5.6 4.09 0.43 
Severe cardiotoxicity  3.5-4.9 4.16 0.40 
Total  3-5.6 4.01 0.42 
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Table No.15 Serum K+ levels in yellow oleander poisoning 
Serum K+ (meq/l) No. of cases   % 
<3.5 7 7.2 
3.5-5 88 90.7 
>5 2 2.1 
 
Relationship between gastric lavage and cardiotoxicity  
 Gastric lavage was given in 90.9% of the cases. In those who were 
given gastric lavage, 39.0% did not develop any cardiotoxicity compared to 
33.3% in those who were not given gastric lavage. The difference between the 
groups was statistically insignificant (p=0.5675). The table below shows the 
details.  
 
Table No.16 Gastric lavage and cardiotoxicity  
 
Cardiotoxicity 
No 
cardiotoxicity 
Some 
cardiotoxicity 
Severe 
cardiotoxicity 
Total 
Gastric 
lavage 
No % No % No % No % 
Given  39 39.0 43 43.0 18 18.0 100 100 
Not given  3 33.3 4 44.5 2 22.2 9 100 
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Treatment given in yellow oleander poisoning  
 
 Most of the patients were given supportive treatment in the form of 
gastric lavage, injection atropine and tablet orciprenaline. Steroids were used 
in 46.8% of cases. Some patients were given tablet salbutamol and tablet 
deriphylline. Few patients received injection sodium bicarbonate. The details 
are given in the table given below.  
 
Table No. 17 Treatment given in yellow oleander poisoning  
 
No. of cases 
Treatment 
No % 
Gastric lavage  100 90.9 
Injection atropine  78 71.6 
Tablet orciprenaline  97 88.2 
Steroids  52 46.8 
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Relationship between cardiotoxicity and duration of hospital stay 
 
  The mean duration of hospital stay was 4.55 days, range being 1-9 
days. The mean duration in no, some and severe cardiotoxicity groups was 
3.64, 4.96 and 5.65 days respectively. The difference between the groups was 
statistically significant (p=0.0001). The details are given in the table below 
and explained using a graph.  
 
Table No. 18 Duration of hospital stay and cardiotoxicity 
 
Duration of 
hospital stay 
No 
cardiotoxicity
Some 
cardiotoxicity
Severe 
cardiotoxicity 
Total 
Mean  3.64 4.96 5.65 4.55 
S.D.  1.62 1.03 1.35 1.57 
p  0.0001 
Range  1-9 
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Outcome  
 
 Out of 111 cases, 86.4% of the cases were discharged well. Death 
occurred in two cases (1.9%, one male and female patient) and 11.7% of the 
patients absconded from the wards. There was no statistically significant 
difference in outcome among males and females (p=0.7002).  
 
Table No. 19 Outcome 
 
Cases 
Male Female Total Outcome 
No. % No. % No. % 
Discharged well  41 82 55 90.2 96 86.4 
Expired  1 2 1 1.6 2 1.9 
Absconded  8 16 5 8.2 13 11.7 
Total  50 100 61 100 111 100 
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Relationship between cardiotoxicity and outcome  
 
 Out of 111 cases, only two deaths occurred. The deaths occurred in 
patients who had severe cardiotoxicity. But there was no statistically 
difference in outcome among no, some and severe cardiotoxicity groups 
(p=0.6182).    
 
Table No. 20 Cardiotoxicity and outcome 
Cardiotoxicity 
No cardiotoxicity 
Some 
cardiotoxicity 
Severe 
cardiotoxicity 
Outcome 
No. % No. % No. % 
Discharged well  31 73.8 46 95.8 19 90.5
Expired  - - - - 2 9.5 
Absconded  11 26.2 2 4.2 - - 
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DISCUSSION 
 
 Yellow oleander poisoning is a common method of deliberate self-harm 
among young adults in Srilanka and southern India. This study was done to 
find out the burden of this poisoning among admissions in general medicine 
wards of Government Rajaji Hospital, Madurai, to analyse the socio-clinical 
aspects, to correlate clinical and biochemical parameters with cardiotoxicity 
and to identify the possible risk factors for cardiotoxicity and outcome.  
 
The incidence of yellow oleander poisoning among total number of 
admissions in general medicine wards of our hospital during the study period 
was 13.2 per 1000 admissions. Though it has been mentioned in previous 
studies that thousands of cases occur in Srilanka every year4, the exact 
incidence in a particular population has not been previously reported. 
   
Among the 111 cases studied, the mean age of patients was 27.05±9.76 
years, range being 13-62 years (pediatric cases not included). 71.7% of the 
cases occurred in the age group between 13-29 years. This observation 
confirms the observation of previous Indian and Srilankan studies that yellow 
oleander poisoning was found commonly among adolescents and young 
adults4,7. Eddleston M et al, in a study of 415 cases in Srilanka observed that 
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the patients were young (mean age 25.8 years, range 11-71). In that study 
more than 50% of women and 35% of men were under 21 years4.  
 
Regarding the sex distribution 54.95% of the cases were females and 
45.05% cases were males, the ratio being 1.22:1. In the present study there 
was only a slight female preponderance when compared to findings of 
previous Indian and Srilankan studies. Eddleston M et al, observed a female : 
male ratio of 1.6:1 in his study involving 415 patients in Srilanka4. Generally 
this poisoning was found to be more common among females when compared 
to males 4,7,25.  
 
Majority of the patients belonged to the upper lower and lower 
socioeconomic class [Kuppuswami, 1962 (modified)]. 72.5% of the patients 
who were earning had income below Rupees two thousand per mth. 70% of 
the patients were daily wage labourers.  
 
70% of the patients were from the rural areas probably due to the fact 
that the plant was easily available and widely grown in rural areas. There was 
no expenditure of money in consuming the poison and for many patients this 
was only poison known to them.  
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Most of the cases occurred during the working hours 6am – 6pm 
(85.5%) when the relatives were away for work or the victims have consumed 
the poison near their workplace.  
 
The intention behind the poisoning was suicidal in 82.9% of the cases. 
The reasons included interpersonal conflict, unemployment, failure to achieve 
goal, situational reaction, grief reaction, physical illness etc. One patient had 
underlying psychiatric illness, schizophrenia. In 15.3% of the patients, 
poisoning attempt was done just to frighten others for some personal gain or to 
resolve conflicts. There were two cases of accidental poisoning among 
adolescents. There were no cases of homicidal poisoning probably due to the 
bitter taste of the poison. The observations regarding the intention behind 
poisoning were similar to that observed by Eddleston M et al 4.  
 
Regarding underlying illness, except for three patients, one case of 
schizophrenia, one case of old anteroseptal myocardial infarction, one case of 
hypertension, none had any previous illness. All the three patients were on 
irregular treatment. Four of the female patients were pregnant while 
consuming the poison and all of them recovered. This was similar to the 
findings observed by Eddleston M et al, who noted that only one patient had 
underlying illness (rheumatic heart disease)8. This observation differed 
markedly from patients with digoxin poisoning. Many of the patients with 
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digoxin poisoning had underlying heart disease and were on multiple drugs 27. 
This observation is important because as a result of young age and previously 
healthy state, the cardiac arrhythmias induced by yellow oleander poisoning 
are unlikely to result from pre-existing conditions.  
 
The electrocardiographic changes that were noted in this study was 
mainly due to depressed conduction. Most common abnormalities were sinus 
bradycardia, ST-T changes suggestive of digoxin effect / toxicity, first-degree 
AV block, third-degree AV block and sino-atrial block. Others included 
second-degree AV block, junctional rhythm, AV dissociation and atrial 
ectopics. The observations were similar to that of Eddleston M et al except 
that tachyarrhythmias (0.5-1%) like atrial flutter, atrial fibrillation, ventricular 
tachycardia and ventricular fibrillation observed by Eddleston M et al were 
not observed in the present study. In the same study 3-6% had 
supraventricular tachycardia and 2% had ventricular ectopics which was not 
observed in the present study8. Mobitz type – II second-degree AV block 
which is not described in digoxin toxicity occurred in two cases28. In yellow 
oleander poisoning arrhythmias due to depressed conduction were more 
common than tachyarrhythmias and thus differs from digoxin poisoning in 
which tachyarrhythmias were found to be more common 27. 
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Depending on the ECG changes patients were divided into no, some 
and severe cardiotoxicity groups and the relationship between various factors 
and cardiotoxicity was studied (Refer definitions in materials and methods). 
Majority (61.8%) of cases showed some form of cardiotoxicity. Severe 
cardiotoxicity was present in approximately 20% of the cases.  
 
The common method of poisoning in the present study was ingestion of 
fruits or seeds in the crushed or chewed form. Three patients had taken the 
outer fleshy covering of the nut and these patients had no cardiotoxicity. 
Toxicological studies in albino rats have shown that all parts of the plant were 
poisonous especially the seeds / kernels of fruit16. Other parts like roots, leaves 
or flowers were not taken. The mean number of seeds / fruits ingested in 
severe (3.85) and some cardiotoxicity groups were (3.47) higher than that in 
no cardiotoxicity group (2.33). The range in no, some and severe 
cardiotoxicity groups were 1-5, 1-10, and 1-18 (seeds/fruits) respectively. 
Although there was a positive correlation between quantity of poison and 
cardiotoxicity in the present study it should be noted that even one seed / fruit 
was found to cause some or severe cardiotoxicity. Relationship between 
quantity of poison and outcome was not present as only two deaths had 
occurred and patients who had taken six and ten seeds had all survived. Two 
patients who died had consumed 5 and 18 seeds respectively. Eddleston M et 
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al (1999) also observed no relationship with seeds ingested and outcome. In 
that study six patients who had died had consumed 10,5,8,1,5 and 2 seeds4. So 
the quantity of poison alone cannot determine outcome, it may be influenced 
by other factors like method of ingestion, consumption in empty stomach or 
not, delay in gastric lavage, treatment given etc.  
 
Majority had taken the seeds / fruits in the crushed form. There was a 
higher incidence of cardiotoxicity in those who had taken the seeds / fruits 
crushed compared to those who had chewed or swallowed the poison. This is 
probably due to the fact that more amount of cardiac glycoside is available to 
be absorbed once the seeds/fruits are crushed. In seven patients who had 
swallowed the seeds, two patients developed some cardiotoxicity and one 
patient developed severe cardiotoxicity. This finding is supported by the fact 
that in Srilanka people usually eat the seeds whole and they develop 
cardiotoxicity. So even the seeds taken as a whole can cause cardiotoxicity but 
to a lesser extent when compared to crushed or chewed form. The method of 
ingestion observed in the present study was similar to that reported in a study 
from Eastern India in which majority (97.33%) of the patients had ingested the 
poison in the crushed form7.  
 
Most of the patients (60.4%) had consumed the poison in empty 
stomach. There was a higher incidence of cardiotoxicity in patients who had 
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consumed the poison in empty stomach than after food. This is probably due 
to the fact that absorption of cardiacglycoside is better in empty stomach. In 
previous studies this relationship was not assessed.  
 
In 42.3% of cases first aid was given at home after the ingestion of 
poison. The commonly used method was to induce vomiting using soap water, 
tamarind water, salt water etc. There was no statistically significant difference 
in cardiotoxicity between patients who were given first aid and those who 
were not given first aid. This is because of the fact that in many patients there 
was a delay in giving first aid. But in patients who were given first aid, delay 
in giving first aid was associated with increased incidence of cardiotoxicity. 
So bringing out the poison early before the poison has passed into intestine 
reduces the incidence of cardiotoxicity in yellow oleander poisoning. The 
relationship between time of first aid and cardiotoxicity was not studied in 
previous reports.  
 
The mean delay in getting admitted to Government Rajaji Hospital, 
Madurai after consumption of poison was 12.72 ±4.6 hrs, the range being 1-62 
hrs. A correlation between delay in getting admitted to our hospital and 
cardiotoxicity could not be obtained probably due to the fact that many 
patients were given first aid and treated outside in other hospitals/institutions 
before being referred to our hospital. Bose TK et al (1999) observed a delay of 
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6-8 hrs7. The reasons for the delay in getting admitted to our hospital in the 
present study would be treatment of patients outside by others doctors and 
lack of adequate transportation in interior rural areas. In patients with high 
suicidal intent the relatives come to know of the poisoning only after several 
hours and this might have contributed to the delay.  
 
The most common symptoms of yellow oleander poisoning in the 
present study were vomiting (73%), numbness of tongue and lips (57.7%), 
giddiness (56.8%) and diarrhea (27.9%). This was similar to findings noted by 
Saravanapavananthan N and Ganeshmoorthy J (1986) who observed vomiting, 
giddiness and diarrhea as the most common symptoms in their study of 170 
cases in Srilanka2. Patients who had either vomiting, diarrhea or altered mental 
status had higher incidence of cardiotoxicity compared to those who did not 
have any one of the above symptoms. Among patients who had at least two or 
all the three of above symptoms 75% developed cardiotoxicity. Thus patients 
with either vomiting, diarrhea or altered mental status should be closely 
monitored for cardiotoxicity. Ellenhorn and Barceloux (1988) have also noted 
that in severe poisoning diarrhea and vomiting are early features20.  
 
The average pulse rate at admission was 80.07±20.9 per minute, range 
being 36-140 per minute. Many patients had a normal pulse rate and rhythm at 
admission only to develop features of cardiotoxicity later usually within a day. 
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Eddleston M et al (1999) has described a patient who remained in sinus 
rhythm for three days before developing second degree AV block4. So patients 
may have to be observed for 3-4 days after ingestion of poison before being 
discharged home.  
 
Hyperkalemia occurs in severe yellow oleander poisoning8. Severe 
hyperkalemia can contribute to atrioventricular (AV) block and depressed 
myocardial excitability19. In the present study hyperkalemia was noted in only 
two out of 97 cases (2.1%) in whom the serum potassium levels were 
measured. Both of these patients had some cardiotoxicity. But there was a 
correlation between serum potassium levels and cardiotoxicity in the present 
study. The mean serum potassium values were higher in some (4.09meq/l) and 
severe cardiotoxicity groups (4.16meq/l) compared to patients with no 
cardiotoxicity (3.85meq/l). Eddleston M et al (2000) noted hyperkalemia in 38 
patients out of 118 cases (32.2%). Very high values of potassium like 
7.2meq/l, 8.4meq/l and 10.8meq/l were observed in that study8. In the present 
study the two patients who had hyperkalemia had values of 5.6 and 5.1meq/l. 
The reason why hyperkalemia was not as common when compared to 
Srilankan study would be that poisoning might have been less severe or due to 
the persistent vomiting due to poisoning per se or due to induced emesis. 
Another reason would be that serial serum potassium measurements were not 
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obtained due to technical constraints and hyperkalemia developing during the 
course of poisoning was missed (serum potassium levels were measured only 
at admission). Moreover the baseline potassium level in the population also 
was not known. Hypokalemia was noted in 7 of our cases. Eddleston M et al, 
(2000) noted hypokalemia in 9 out of 118 cases8. Hypokalemia may be 
probably due to persistent vomiting due to poisoning per se or due to induced 
emesis. Hypokalemia can exacerbate cardiac glycoside toxicity as if facilitates 
enhanced binding of cardiac glycosides to Na+ -K+ ATPase pump22. Both 
hyperkalemia and hypokalemia are dangerous in yellow oleander poisoning 
and serial monitoring of potassium levels and adequate treatment is necessary. 
Severe hyperkalemia may require treatment with antidigoxin Fab fragments18.  
 
There was no statistically significant difference in cardiotoxicity 
between patients who were given gastric lavage and those who were not given 
gastric lavage. Gastric lavage is most useful when started within 60 minutes 
after ingestion24. Early gastric lavage is more important than whether gastric 
lavage is given or not in reducing the incidence of cardiotoxicity. This 
relationship was not assessed in previous published reports.                            
 
Most of the patients were treated with supportive measures like gastric 
lavage, injection atropine, tablet orciprenaline and in about 50% of the cases 
steroids were used. There are no scientific studies or trials to support the use 
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of steroids in yellow oleander poisoning. Activated charcoal, temporary 
cardiac pacing and antidigoxin Fab fragments were not used due to 
economical and technical constraints.  
 
The mean duration of hospital stay in the present study was 4.55 days, 
range being 1-9 days. Those patients with some and severe cardiotoxicity had 
increased duration of hospital stay when compared to patients with no 
cardiotoxicity. This was similar to findings observed by Bose TK et al (1999) 
who observed a median hospital stay of 5 days7.  
 
Death occurred in two cases (one male and female patient) within one 
hour after admission. The male patient had atrioventricular dissociation while 
the female patient died before ECG could be taken. The case fatality rate was 
1.9%. Bose TK et al (1999) observed a case fatality rate of 4.6% among 300 
patients in eastern India7. In Srilankan studies, Eddleston M et al observed a 
case fatality rate of approximately 10%4. The lower case fatality rate in the 
present study may be due to less severe poisoning in Tamilnadu when 
compared to that in Srilanka and probably due to lesser number of patients 
studied. As the deaths were very few, there was no statistically significant 
difference in outcome among no, some and severe cardiotoxicity groups and 
also there was no statistically significant difference in outcome among male 
and female patients.   
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Areas of further work 
1. The efficacy of anti–digoxin Fab fragments in treating serious 
cardiac arrhythmias induced by yellow oleander has been 
established by Eddleston M et al (2000) in the only small 
randomised clinical trial involving 66 patients10. Further studies 
are required to confirm the efficacy of anti-digoxin Fab 
fragments in treating serious cardiac arrhythmias induced by 
yellow oleander. 
2. Multiple doses of activated charcoal was found to be safe and 
more effective than single dose activated charcoal in reducing 
death and life threatening cardiac arrhythmias after yellow 
oleander poisoning in the only single–blind, randomised, 
placebo-controlled trial in Srilanka9. Further studies are required 
to confirm the superiority of multiple doses of activated charcoal 
over single dose activated charcoal in yellow oleander 
poisoning. 
3. Focal myocardial edema has been noted in cases of yellow 
oleander poisoning7. So studies can be taken up to assess 
whether glucocorticoids have any role in improving outcome in 
this poisoning.  
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CONCLUSIONS 
 
1. The incidence of yellow oleander poisoning in general medicine wards 
of Government Rajaji Hospital, Madurai during the study period was 
13.2 per 1000 admissions. 
 
2. Yellow oleander poisoning was most commonly observed among 
young adults and adolescents.  
 
3. Although there was a slight female preponderance the difference was 
not statistically significant.  
 
4. Most of the patients were from rural areas belonging to upper lower 
and lower socio-economic class.  
 
5. Most of the cases occurred during day time (6am – 6pm).  
 
6. In majority of cases, the intention was suicidal secondary to 
interpersonal conflict, grief reaction, situational reaction, 
unemployment etc.  
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7. The most common symptoms of yellow oleander poisoning in the 
present study were vomiting, numbness of tongue and lips, giddiness 
and diarrhea.  
 
8. Electrocardiographic changes that were noted were mainly due to 
depressed conduction. Most common abnormalities were sinus 
bradycardia, ST-T changes similar to digoxin effect / toxicity, first-
degree AV block, third-degree AV block and sino-atrial block.  
 
9. Hyperkalemia as a manifestation of yellow oleander poisoning was 
uncommon in the present study compared to Srilankan studies.  
 
10. There was a higher incidence of cardiotoxicity as the quantity of poison 
increased but even ingestion of one seed / fruit was found to cause 
severe cardiotoxicity.  
 
11. There was a higher incidence of cardiotoxicity in those who had taken 
the seeds / fruits crushed when compared to those who had chewed or 
swallowed the poison.  
 
12. Cardiotoxicity was found to be higher in patients who had consumed 
the poison in empty stomach than after food.       
 
 61
13. Delay in inducing emesis or giving gastric lavage was associated with 
increased incidence of cardiotoxicity.  
 
14. The occurrence of cardiotoxicity was higher in patients who had 
vomiting, diarrhea or altered mental status compared to patients who 
did not have any of these symptoms.  
 
15. The mean serum potassium values at presentation were higher in 
patients who had cardiotoxicity when compared to patients who had no 
cardiotoxicity.  
 
16. Case fatality rate was low in the present study when compared to 
previous Srilankan and Indian studies.  
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SUMMARY 
 
 Yellow oleander poisoning is a common method of suicide in South 
India and Srilanka with thousands of cases occurring in Srilanka each year at 
present. This study was undertaken to find out the incidence of yellow 
oleander poisoning in our hospital, to study the socio-clinical aspects, to find 
out correlation between clinical and biochemical parameters with 
electrocardiographic changes and to find out possible risk factors for 
cardiotoxicity and outcome. 
 After institutional ethical clearance, with an informed consent and with 
inclusion and exclusion criteria 111 cases of yellow oleander poisoning were 
included in the study and were evaluated on social, clinical, biochemical and 
electrocardiographic aspects. The data were entered in Microsoft Excel spread 
sheet and analysed statistically. 
 The incidence of yellow oleander poisoning in general medicine wards 
of our hospital was 13.2 per 1000 admissions. 54.95% of the cases were 
females. The mean age of poisoning was 27.05 ± 9.76 years. The intention 
was suicidal in majority. The most common symptoms were vomiting, 
numbness of tongue and lips, giddiness and diarrhea. The most common 
abnormal ECG findings were sinus bradycardia, ST-T changes similar to that 
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described for digoxin effect/ toxicity, sino-atrial block, first-degree AV block 
and third-degree AV block. Depending on the ECG changes, patients were 
decided into no, some and severe cardiotoxicity groups and relationship 
between various factors and cardiotoxicity analysed. The mean number of 
seeds / fruits ingested in patients who had cardiotoxicity was higher than in 
patients who had no cardiotoxicity. Majority had taken the poison crushed and 
in empty stomach which resulted in greater cardiotoxicity. Delay in inducing 
emesis or giving gastric lavage was associated with greater cardiotoxicity. The 
occurrence of cardiotoxicity was higher in patients who had vomiting, 
diarrhea or altered mental status. The mean serum potassium values at 
presentation was higher in patients who had cardiotoxicity. Hyperkalemia was 
noted in only two cases. The mean duration of hospital stay was 4.55 ± 1.57 
days and was higher in patients who had cardiotoxicity. The case fatality rate 
was 1.9%. 
 
 Yellow oleander poisoning was found to be a common method of 
suicide among young adults and adolescents in this part of the country and 
was slightly more common in females. It accounted for 13.1% of cases among 
the total number of poisoning cases during the study period. Most of the 
patients were from rural areas belonging to upper lower and lower socio-
economic class. The most common symptoms were vomiting, numbness of 
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tongue and lips, giddiness and diarrhea. The most common 
electrocardiographic abnormalities were sinus bradycardia, ST-T changes 
similar to digoxin effect/toxicity, first-degree AV block, third-degree AV 
block and sino-atrial block. Hyperkalemia was found to be uncommon when 
compared to previous Srilankan studies. The occurrence of cardiotoxicity was 
greater in patients who had taken the poison crushed and in empty stomach, 
who had taken more quantity of poison, in whom there was a delay in 
inducing emesis or giving gastric lavage, who had vomiting, diarrhea or 
altered mental status and who had higher serum potassium levels at admission. 
The more severe the cardiotoxicity more was the duration of hospital stay. The 
case fatality rate was low when compared to previous studies.  
  
 Although this study could identify the risk factors for cardiotoxicity, 
the risk factors associated with poor outcome could not be well established as 
the deaths were very few. Hence further studies are required to identify risk 
factors associated with poor outcome in this poisoning. Further studies are 
also required to assess the role of glucocorticoids in improving outcome. The 
benefit reported with multiple doses of activated charcoal and anti-digoxin 
Fab fragments also need to be confirmed by further studies.    
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APPENDIX II 
PROFORMA 
SOCIO-CLINICAL, BIOCHEMICAL AND ELECTROCARDIOGRAPHIC 
ASPECTS OF YELLOW OLEANDER POISONING 
 
Name :                                Age:                Sex: M/F    IP No.: 
Occupation:   Income:    Serial No.: 
DOA:  DOD:   Duration of Hospital stay: 
Religion: H/M/C/ Others   
Marital status: M/UM/ Separated /Divorcee /  Widow/ Widower  
Address: 
 
Social Profile  
Place of Ingestion : 
Part ingested  : Leaves / Flower / Fruit / Seed /Roots / Others 
Quantity of poison  :  
Method of ingestion : Crushed / Chewed / Swallowed / Others  
Mixed with  : Water/Oil/Other poison/Alcohol/Food /Others  
Consumption in  : Empty Stomach / After Food (       )hrs  
Intention   : Suicidal / Accidental / Homicidal / Others  
Reason for ingestion :    
 
Why this poison was preferred over others? 
 
Are there other victims? Yes / no If yes relation to case 
 
Time Profile  
Time of ingestion  : 
Time after which family members / others came to know: 
First aid at home  :    Time  : 
Treatment by other Doctors:   Time : 
       Time of Admission: 
Underlying Psychiatric Disease Yes / No  If yes  
Other diseases:  HIV / Leprosy / Heart disease / PTB / BAsthma /  
Epilepsy / DM / HT / Jaundice / Others  
Women - L.M.P.   Pregnant : Yes / No  
 
Clinical profile  
GI  - Nausea/Vomiting/Abdominal pain/Diarrhea / Anorexia  
CNS - Giddiness/Headache/Fatigue/Weakness/Numbness of tongue &  
lips /Altered mental status / Seizures 
Visual - Blurred vision/Scotomas / Flashes of light / Xanthopsia  
Cardiac - Palpitations/ Shortness of breath / Chest pain/ Chest discomfort 
 
Physical examination  PR Rhythm   Volume 
BP  RR  Febrile / Afebrile   Dehydration : 
        No / Some / Severe   
Pallor / Icterus / Cyanosis / Clubbing / Lymphadenopathy / Pedaledema  
CNS: Level of consciousness  
Tone   Deep Tendon reflexes    Plantar  
Other systems:  
 
 
 
Investigations            ECG in all leads with rhythm strip 
Date     
Blood urea (mg/dl)    
Sugar (mg/dl)    
Creatinine (mg/dl)    
Na+ (meq/l)    
K+ (meq/l)    
Cl- (meq/l)    
HCO3- (meq/l)    
 
Treatment given   
Gastric lavage   - Yes / No  Psychiatry Opinion  
Activated Charcoal   - Yes / No 
Inj. Atropine    - Yes / No 
Tab. Orciprenaline   - Yes / No 
Steroids    - Yes / No 
Others    - Yes / No If yes specify  
 
Outcome: Improved/ Expired / AMA/Absconded / Discharged at request   
  
 
YELLOW OLEANDER - TREE  
 
 
 
 
YELLOW OLEANDER – FLOWERS  
 
YELLOW OLEANDER - FRUIT  
 
 
 
YELLOW OLEANDER – NUT  
 
Selected ECGs of patients of Yellow Oleander poisoning  
 
 
 
 
 
 
 
APPENDIX I  
APPROVAL FROM ETHICAL COMMITTEE 
 
 
 
MASTER CHART KEY 
YELLOW OLEANDER POISONING 
 
1. Sex   Male – 1  Female – 2 
 
2. Marital Status  Married  - 1   Unmarried – 2  Separated – 3 
   Divorcee – 4  Widow – 5   Widower – 6  
   Not recorded – 9  
 
3. Part ingested  Fruit – 1  Seed / kernel – 2  Flower – 3 
   Leaves – 4  Root – 5   Other parts – 9  
 
4. Method of ingestion Crushed – 1   Chewed -2   
    Swallowed – 3  Others – 4  
 
5. Consumption in   Empty stomach – 1  After Food – 2     
 
6. Intention   Suicidal – 1  Accidental – 2   
   Homicidal – 3  Others  - 4  
 
7. First Aid  Æ Given Æ 1   Not given Æ 2  
 
8. Treatment by other doctors  Yes – 1  No – 2  
9. Vomiting     Yes – 1  No – 2  
10. Abdominal Pain  Yes – 1  No – 2  
11. Diarrhea    Yes – 1  No – 2  
12. Giddiness    Yes – 1  No – 2  
13. Numbness of tongue & lips  Yes – 1  No – 2     
14. Altered mental status   Yes – 1  No – 2  
15. Blurred vision    Yes – 1  No – 2  
16. Palpitations   Yes – 1  No – 2  
17. Shortness of breath   Yes – 1  No – 2  
18. Pulse rhythm    Regular -1  Irregular – 2  
19. Sinus rhythm    Yes – 1  No – 2  
20. Sinus bradycardia   Yes – 1  No – 2  
21. Sinus arrestor exit block  Yes – 1  No – 2       
22. Atrial Ectopics     Yes – 1  No – 2  
23. Junctional rhythm   Yes – 1  No – 2  
24. AV Dissociation   Yes – 1  No – 2       
25. 1° AV block    Yes – 1  No – 2   
 
26. 2° AV block    Mobitz Type I block – 1  No block – 2  
     Mobitz Type II block – 3  
 
27. 3° AV block    Yes – 1  No – 2  
28. ST – T Changes   Yes – 1  No – 2     
29. Gastric lavage   Yes – 1  No – 2    
30. Injection Atropine   Yes – 1  No – 2     
31. Tablet Orciprenaline   Yes – 1  No – 2     
32. Steroids     Yes – 1  No – 2     
 
33. Outcome   Improved – 1    Expired – 2  
    Against Medical Advice – 3  Absconded – 4 
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